75 filings
Page 3 of 4
8-K
2k8ah nd8v50qv
16 May 22
Aerovate Therapeutics Announces First Quarter 2022 Financial Results
8:00am
DEFA14A
s8srcua
29 Apr 22
Additional proxy soliciting materials
4:47pm
DEF 14A
o1hccl9
29 Apr 22
Definitive proxy
4:45pm
8-K
edqvma fs8wh
29 Apr 22
Entry into a Material Definitive Agreement
8:00am
S-8
ujvb79 ej
30 Mar 22
Registration of securities for employees
4:56pm
10-K
ve2hymo jk
30 Mar 22
Annual report
4:51pm
8-K
onrhqyg2luw9
30 Mar 22
Aerovate Therapeutics Announces Full-Year 2021 Financial Results
4:45pm
8-K
vnlhllp44du7uyy0tq6
15 Dec 21
Aerovate Therapeutics Announces Initiation of IMPAHCT Phase 2b/Phase 3 Trial of AV-101 In Pulmonary Arterial Hypertension
8:00am
8-K
ackbcogtl1i7w g6jpou
15 Nov 21
Aerovate Therapeutics Announces Third Quarter 2021 Financial Results
8:00am
10-Q
n9j3yie4
16 Aug 21
Quarterly report
8:08am
8-K
m7nck
16 Aug 21
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
8:05am
8-K
9a291yq
12 Aug 21
Entry into a Material Definitive Agreement
5:27pm
8-K
4sm7s 2ap
19 Jul 21
Aerovate Therapeutics Appoints Allison Dorval To Its Board of Directors
8:18am
8-K
j58 spx170
2 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:33pm
S-8
8ps 8t4n512y
30 Jun 21
Registration of securities for employees
5:02pm
424B4
oeufvlzxpc jekw0hi
30 Jun 21
Prospectus supplement with pricing info
4:59pm
EFFECT
1mq6nfkjt6 bg
30 Jun 21
Notice of effectiveness
12:15am
S-1MEF
zucp1
29 Jun 21
Registration of additional securities for an S-1
7:10pm